Dr. Anne-Marie Mes-Masson

Researcher
  • Centre de recherche de Centre hospitalier de L’Université de Montréal
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Ovarian Cancer

    Metabolomics standardization process

    A pan-Canadian team of researchers is collaborating on new tools to help better understand cancers, thanks to new funding from the Terry Fox Research Institute (TFRI) and the Marathon of Hope Cancer ...

    Read More
  • Completed
    Multiple Cancers

    Montreal Cancer Consortium Pilot for the Marathon of Hope Cancer Centres

    Leading researchers, cancer centres and hospitals in Montreal have partnered with The Terry Fox Research Institute to generate new advances in personalized and precision medicine and improve treatment...

    Read More
  • Completed
    Ovarian Cancer

    Canadian ovarian cancer research consortium

    Ovarian cancer is the fifth-leading cause of cancer-related deaths in the western world. More than one in four women do not respond to standard first-line chemotherapy treatment — an alarming nu...

    Read More

Related News & Events

  • TFRI News|January 06, 2026

    Long-time Terry Fox-funded researchers, leaders and mentors Drs. Anne-Marie Mes-Masson and John Bell appointed to the Order of Canada

    Drs. Anne-Marie Mes-Masson and John Bell, two distinguished researchers with deep and long-time connections to the Terry Fox Research Institute, have ...

  • TFRI News|November 12, 2024

    Eight pan-Canadian research teams receive newly created TFRI-MOHCCN Technology Development Awards

    New joint funding initiative from TFRI and the MOHCCN will support the deployment of novel technologies to accelerate precision medicine for cancer.

  • Research Highlight|October 21, 2021

    TFRI-funded biobank used to make important findings that could help personalize and improve treatments for ovarian cancers

    Twelve years after it first received TFRI funding, the resource continues to be invaluable for researchers.

  • Press Release|July 21, 2021

    Distinguished Toronto Scientist Dr. Jim Woodgett Takes Up Leadership of Terry Fox Research Institute on August 1

    The Board of Directors of the Terry Fox Research Institute (TFRI) announces the appointment of Jim Woodgett, a senior scientist based at the Lunenfeld...

  • Press Release|June 09, 2021

    Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada

    The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Maratho...

  • Research Highlight|August 17, 2020

    Quantifying PTEN loss could help stratify risk of relapse for patients with prostate cancer, study finds

    A research team in Kingston, Ontario has identified the specific threshold at which PTEN loss becomes clinically significant, presenting a new tool th...

  • Press Release|July 11, 2019

    TFRI and partners react to investment of $150M by Federal Minister of Health to create “Team Canada of Cancer Research”

    The federal Minister of Health, Ginette Petitpas Taylor, announced today an investment of $150 million over five years by the Government of Canada for...

  • All News & Events